ARCHIVES

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

This article is from The Cancer Letter archive.

Vol. 04 No. 06 | February 10, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

May 18, 2007

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991